| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.82B | 21.43B | 21.02B | 19.56B | 18.13B | 17.17B |
| Gross Profit | 7.80B | 7.50B | 7.38B | 6.70B | 7.08B | 6.78B |
| EBITDA | 1.67B | 1.45B | 1.64B | 1.10B | 1.80B | 1.65B |
| Net Income | 124.00M | 13.00M | 835.00M | 448.00M | 965.00M | 872.00M |
Balance Sheet | ||||||
| Total Assets | 26.10B | 25.90B | 26.43B | 25.52B | 24.91B | 24.06B |
| Cash, Cash Equivalents and Short-Term Investments | 7.54B | 7.55B | 7.18B | 6.44B | 6.80B | 7.00B |
| Total Debt | 458.00M | 494.00M | 582.00M | 682.00M | 773.00M | 1.54B |
| Total Liabilities | 7.21B | 6.89B | 7.28B | 7.27B | 6.95B | 6.85B |
| Stockholders Equity | 18.89B | 19.02B | 19.15B | 18.25B | 17.96B | 17.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 762.00M | 1.14B | -38.00M | 1.14B | 37.00M |
| Operating Cash Flow | 0.00 | 1.13B | 1.49B | 341.00M | 1.73B | 1.66B |
| Investing Cash Flow | 0.00 | -474.00M | -468.00M | -450.00M | -666.00M | -1.67B |
| Financing Cash Flow | 0.00 | -347.00M | -302.00M | -316.00M | -1.30B | -378.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥34.87B | 7.75 | ― | 3.59% | 7.84% | 29.36% | |
73 Outperform | ¥45.76B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
66 Neutral | ¥105.38B | 13.03 | ― | 3.53% | -1.02% | -40.96% | |
66 Neutral | ¥124.47B | 10.42 | 12.89% | 3.40% | 2.68% | 23.60% | |
65 Neutral | ¥8.98B | 6.40 | ― | 3.73% | 3.28% | -69.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.75B | 4.98 | ― | 4.13% | 4.55% | -12.71% |